Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice

Journal of Experimental Medicine

Volumn 212, Issue 4, 2015, Pages 469-480

  Gao, Liang ^a   Brenner, David ^a   Llorens Bobadilla, Enric ^a   Saiz Castro, Gonzalo ^a   Frank, Tobias ^b   Wieghofer, Peter ^c   Hill, Oliver ^d   Thiemann, Meinolf ^d   Karray, Saoussen ^e   Prinz, Marco ^c   Weishaupt, Jochen H ^f   Martin Villalba, Ana ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d APOGENIX GMBH   (Germany)

^e INSERM   (France)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; FAS ANTIGEN; FAS LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL INFILTRATION; CELL LINEAGE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DOWN REGULATION; GENE SILENCING; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MICROGLIA; MONOCYTE; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; VENTRAL TEGMENTUM; ANIMAL; ANTAGONISTS AND INHIBITORS; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; PARKINSONISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; FAS LIGAND PROTEIN; IMMUNITY, INNATE; INFLAMMATION; MICE; MICE, KNOCKOUT; MYELOID CELLS; PARKINSONIAN DISORDERS;

EID: 84928266280     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20132423     Document Type: Article

References (55)

1. Adachi, M., S. Suematsu, T. Suda, D. Watanabe, H. Fukuyama, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1996. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA. 93:2131-2136. http://dx.doi.org/10.1073/pnas.93.5.2131
2. Ahmed, I., R. Tamouza, M. Delord, R. Krishnamoorthy, C. Tzourio, C. Mulot, M. Nacfer, J.-C. Lambert, P. Beaune, P. Laurent-Puig, et al. 2012. Association between Parkinson's disease and the HLA-DRB1 locus. Mov. Disord. 27:1104-1110. http://dx.doi.org/10.1002/mds.25035
3. Ajami, B., J.L. Bennett, C. Krieger, K.M. McNagny, and F.M.V. Rossi. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14:1142-1149. http://dx.doi.org/10.1038/nn.2887
4. Brochard, V., B. Combadière, A. Prigent, Y. Laouar, A. Perrin, V. Beray-Berthat, O. Bonduelle, D. Alvarez-Fischer, J. Callebert, J.M. Launay, et al. 2009. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119:182-192. http://dx.doi.org/10.1172/JCI36470
5. Butovsky, O., S. Siddiqui, G. Gabriely, A.J. Lanser, B. Dake, G. Murugaiyan, C.E. Doykan, P.M. Wu, R.R. Gali, L.K. Iyer, et al. 2012. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Invest. 122:3063-3087. http://dx.doi.org/10.1172/JCI62636
6. Butovsky, O., M.P. Jedrychowski, C.S. Moore, R. Cialic, A.J. Lanser, G. Gabriely, T. Koeglsperger, B. Dake, P.M. Wu, C.E. Doykan, et al. 2014. Identification of a unique TGF-Β-dependent molecular and functional signature in microglia. Nat. Neurosci. 17:131-143. http://dx.doi.org/10.1038/nn.3599
7. Cho, I.-H., J. Hong, E.C. Suh, J.H. Kim, H. Lee, J.E. Lee, S. Lee, C.-H. Kim, D.W. Kim, E.-K. Jo, et al. 2008. Role of microglial IKKΒ in kainic acid-induced hippocampal neuronal cell death. Brain. 131:3019-3033. http://dx.doi.org/10.1093/brain/awn230
8. Corsini, N.S., I. Sancho-Martinez, S. Laudenklos, D. Glagow, S. Kumar, E. Letellier, P. Koch, M. Teodorczyk, S. Kleber, S. Klussmann, et al. 2009. The death receptor CD95 activates adult neural stem cells for working memory formation and brain repair. Cell Stem Cell. 5:178-190. http://dx.doi.org/10.1016/j.stem.2009.05.004
9. Cros, J., N. Cagnard, K. Woollard, N. Patey, S.-Y. Zhang, B. Senechal, A. Puel, S.K. Biswas, D. Moshous, C. Picard, et al. 2010. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 33:375-386. http://dx.doi.org/10.1016/j.immuni.2010.08.012
10. Cui, Y.-Z., H. Hisha, G.-X. Yang, T.-X. Fan, T. Jin, Q. Li, Z. Lian, and S. Ikehara. 2002. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant. 30:843-849. http://dx.doi.org/10.1038/sj.bmt.1703766
11. Członkowska, A., M. Kohutnicka, I. Kurkowska-Jastrzębska, and A. Członkowski. 1996. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration. 5:137-143. http://dx.doi.org/10.1006/neur.1996.0020
12. Dauer, W., and S. Przedborski. 2003. Parkinson's disease: mechanisms and models. Neuron. 39:889-909. http://dx.doi.org/10.1016/S0896-6273(03)00568-3
13. Demjen, D., S. Klussmann, S. Kleber, C. Zuliani, B. Stieltjes, C. Metzger, U.A. Hirt, H. Walczak, W. Falk, M. Essig, et al. 2004. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat. Med. 10:389-395. http://dx.doi.org/10.1038/nm1007
14. Desbarats, J., R.B. Birge, M. Mimouni-Rongy, D.E. Weinstein, J.-S. Palerme, and M.K. Newell. 2003. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5:118-125. http://dx.doi.org/10.1038/ncb916
15. Diserbo, M., A. Agin, I. Lamproglou, J. Mauris, F. Staali, E. Multon, and C. Amourette. 2002. Blood-brain barrier permeability after gamma whole-body irradiation: an in vivo microdialysis study. Can. J. Physiol. Pharmacol. 80:670-678. http://dx.doi.org/10.1139/y02-070
16. Ferrer, I., R. Blanco, B. Cutillas, and S. Ambrosio. 2000. Fas and Fas-L expression in Huntington's disease and Parkinson's disease. Neuropathol. Appl. Neurobiol. 26:424-433. http://dx.doi.org/10.1046/j.1365-2990.2000.00267.x
17. Frank, T., F. Klinker, B.H. Falkenburger, R. Laage, F. Lühder, B. Göricke, A. Schneider, H. Neurath, H. Desel, D. Liebetanz, et al. 2012. Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease. Brain. 135:1914-1925. http://dx.doi.org/10.1093/brain/aws054
18. Funk, N., P. Wieghofer, S. Grimm, R. Schaefer, H.-J. Bühring, T. Gasser, and S. Biskup. 2013. Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease. Mov. Disord. 28:392-395. http://dx.doi.org/10.1002/mds.25300
19. Gao, X., H. Chen, M.A. Schwarzschild, and A. Ascherio. 2011. Use of ibuprofen and risk of Parkinson disease. Neurology. 76:863-869. http://dx.doi.org/10.1212/WNL.0b013e31820f2d79
20. Ginhoux, F., M. Greter, M. Leboeuf, S. Nandi, P. See, S. Gokhan, M.F. Mehler, S.J. Conway, L.G. Ng, E.R. Stanley, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 330:841-845. http://dx.doi.org/10.1126/science.1194637
21. Goldmann, T., P. Wieghofer, P.F. Müller, Y. Wolf, D. Varol, S. Yona, S.M. Brendecke, K. Kierdorf, O. Staszewski, M. Datta, et al. 2013. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat. Neurosci. 16:1618-1626. http://dx.doi.org/10.1038/nn.3531
22. Grozdanov, V., C. Bliederhaeuser, W.P. Ruf, V. Roth, K. Fundel-Clemens, L. Zondler, D. Brenner, A. Martin-Villalba, B. Hengerer, J. Kassubek, et al. 2014. Inflammatory dysregulation of blood monocytes in Parkinson's disease patients. Acta Neuropathol. 128:651-663. http://dx.doi.org/10.1007/s00401-014-1345-4
23. Hayley, S., S.J. Crocker, P.D. Smith, T. Shree, V. Jackson-Lewis, S. Przedborski, M. Mount, R. Slack, H. Anisman, and D.S. Park. 2004. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neurosci. 24:2045-2053. http://dx.doi.org/10.1523/JNEUROSCI.4564-03.2004
24. Haynes, S.E., G. Hollopeter, G. Yang, D. Kurpius, M.E. Dailey, W.-B. Gan, and D. Julius. 2006. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9:1512-1519. http://dx.doi.org/10.1038/nn1805
25. Karray, S., C. Kress, S. Cuvellier, C. Hue-Beauvais, D. Damotte, C. Babinet, and M. Lévi-Strauss. 2004. Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J. Immunol. 172:2118-2125. http://dx.doi.org/10.4049/jimmunol.172.4.2118
26. Kierdorf, K., D. Erny, T. Goldmann, V. Sander, C. Schulz, E.G. Perdiguero, P. Wieghofer, A. Heinrich, P. Riemke, C. Hölscher, et al. 2013a. Microglia emerge from erythromyeloid precursors via Pu.1-and Irf8-dependent pathways. Nat. Neurosci. 16:273-280. http://dx.doi.org/10.1038/nn.3318
27. Kierdorf, K., N. Katzmarski, C.A. Haas, and M. Prinz. 2013b. Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias. PLoS ONE. 8:e58544. http://dx.doi.org/10.1371/journal.pone.0058544
28. Kleber, S., I. Sancho-Martinez, B. Wiestler, A. Beisel, C. Gieffers, O. Hill, M. Thiemann, W. Mueller, J. Sykora, A. Kuhn, et al. 2008. Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell. 13:235-248. http://dx.doi.org/10.1016/j.ccr.2008.02.003
29. Kokovay, E., and L.A. Cunningham. 2005. Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease. Neurobiol. Dis. 19:471-478. http://dx.doi.org/10.1016/j.nbd.2005.01.023
30. Landau, A.M., K.C. Luk, M.-L. Jones, R. Siegrist-Johnstone, Y.K. Young, E. Kouassi, V.V. Rymar, A. Dagher, A.F. Sadikot, and J. Desbarats. 2005. Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease. J. Exp. Med. 202:575-581. http://dx.doi.org/10.1084/jem.20050163
31. Letellier, E., S. Kumar, I. Sancho-Martinez, S. Krauth, A. Funke-Kaiser, S. Laudenklos, K. Konecki, S. Klussmann, N.S. Corsini, S. Kleber, et al. 2010. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity. 32:240-252. http://dx.doi.org/10.1016/j.immuni.2010.01.011
32. Leuschner, F., P. Dutta, R. Gorbatov, T.I. Novobrantseva, J.S. Donahoe, G. Courties, K.M. Lee, J.I. Kim, J.F. Markmann, B. Marinelli, et al. 2011. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 29:1005-1010. http://dx.doi.org/10.1038/nbt.1989
33. Liberatore, G.T., V. Jackson-Lewis, S. Vukosavic, A.S. Mandir, M. Vila, W.G. McAuliffe, V.L. Dawson, T.M. Dawson, and S. Przedborski. 1999. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5:1403-1409. http://dx.doi.org/10.1038/70978
34. Martin-Villalba, A., E. Llorens-Bobadilla, and D. Wollny. 2013. CD95 in cancer: tool or target? Trends Mol. Med. 19:329-335. http://dx.doi.org/10.1016/j.molmed.2013.03.002
35. McGeer, P.L., and E.G. McGeer. 2008. Glial reactions in Parkinson's disease. Mov. Disord. 23:474-483. http://dx.doi.org/10.1002/mds.21751
36. Mildner, A., H. Schmidt, M. Nitsche, D. Merkler, U.-K. Hanisch, M. Mack, M. Heikenwalder, W. Brück, J. Priller, and M. Prinz. 2007. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 10:1544-1553. http://dx.doi.org/10.1038/nn2015
37. Mildner, A., M. Mack, H. Schmidt, W. Brück, M. Djukic, M.D. Zabel, A. Hille, J. Priller, and M. Prinz. 2009. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain. 132:2487-2500. http://dx.doi.org/10.1093/brain/awp144
38. Mildner, A., B. Schlevogt, K. Kierdorf, C. Böttcher, D. Erny, M.P. Kummer, M. Quinn, W. Brück, I. Bechmann, M.T. Heneka, et al. 2011. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J. Neurosci. 31:11159-11171. http://dx.doi.org/10.1523/JNEUROSCI.6209-10.2011
39. Mogi, M., M. Harada, T. Kondo, Y. Mizuno, H. Narabayashi, P. Riederer, and T. Nagatsu. 1996. The soluble form of Fas molecule is elevated in parkinsonian brain tissues. Neurosci. Lett. 220:195-198. http://dx.doi.org/10.1016/S0304-3940(96)13257-2
40. Peter, M.E., R.C. Budd, J. Desbarats, S.M. Hedrick, A.-O. Hueber, M.K. Newell, L.B. Owen, R.M. Pope, J. Tschopp, H. Wajant, et al. 2007. The CD95 receptor: apoptosis revisited. Cell. 129:447-450. http://dx.doi.org/10.1016/j.cell.2007.04.031
41. Priller, J., A. Flügel, T. Wehner, M. Boentert, C.A. Haas, M. Prinz, F. Fernández-Klett, K. Prass, I. Bechmann, B.A. de Boer, et al. 2001. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat. Med. 7:1356-1361. http://dx.doi.org/10.1038/nm1201-1356
42. Prinz, M., and A. Mildner. 2011. Microglia in the CNS: immigrants from another world. Glia. 59:177-187. http://dx.doi.org/10.1002/glia.21104
43. Ransohoff, R.M., and A.E. Cardona. 2010. The myeloid cells of the central nervous system parenchyma. Nature. 468:253-262. http://dx.doi.org/10.1038/nature09615
44. Rodriguez, M., L. Alvarez-Erviti, F.J. Blesa, M.C. Rodríguez-Oroz, A. Arina, I. Melero, L.I. Ramos, and J.A. Obeso. 2007. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease. Neurobiol. Dis. 28:316-325. http://dx.doi.org/10.1016/j.nbd.2007.07.024
45. Ros-Bernal, F., S. Hunot, M.T. Herrero, S. Parnadeau, J.-C. Corvol, L. Lu, D. Alvarez-Fischer, M.A. Carrillo-de Sauvage, F. Saurini, C. Coussieu, et al. 2011. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc. Natl. Acad. Sci. USA. 108:6632-6637. http://dx.doi.org/10.1073/pnas.1017820108
46. Roths, J.B., E.D. Murphy, and E.M. Eicher. 1984. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159:1-20. http://dx.doi.org/10.1084/jem.159.1.1
47. Schulz, C., E. Gomez Perdiguero, L. Chorro, H. Szabo-Rogers, N. Cagnard, K. Kierdorf, M. Prinz, B. Wu, S.E.W. Jacobsen, J.W. Pollard, et al. 2012. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 336:86-90. http://dx.doi.org/10.1126/science.1219179
48. Simunovic, F., M. Yi, Y. Wang, L. Macey, L.T. Brown, A.M. Krichevsky, S.L. Andersen, R.M. Stephens, F.M. Benes, and K.C. Sonntag. 2009. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain. 132:1795-1809. http://dx.doi.org/10.1093/brain/awn323
49. Taylor, D.L., F. Jones, E.S.F.C.S. Kubota, and J.M. Pocock. 2005. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α-induced neurotoxicity in concert with microglial-derived Fas ligand. J. Neurosci. 25:2952-2964. http://dx.doi.org/10.1523/JNEUROSCI.4456-04.2005
50. Terrazzino, S., A. Bauleo, A. Baldan, and A. Leon. 2002. Peripheral LPS administrations up-regulate Fas and FasL on brain microglial cells: a brain protective or pathogenic event? J. Neuroimmunol. 124:45-53. http://dx.doi.org/10.1016/S0165-5728(02)00013-9
51. Venderova, K., and D.S. Park. 2012. Programmed cell death in Parkinson's disease. Cold Spring Harb. Perspect. Med. 2:a009365. http://dx.doi.org/10.1101/cshperspect.a009365
52. Wu, D.C., V. Jackson-Lewis, M. Vila, K. Tieu, P. Teismann, C. Vadseth, D.K. Choi, H. Ischiropoulos, and S. Przedborski. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22:1763-1771.
53. Yona, S., and S. Jung. 2010. Monocytes: subsets, origins, fates and functions. Curr. Opin. Hematol. 17:53-59. http://dx.doi.org/10.1097/MOH.0b013e3283324f80
54. Yona, S., K.-W. Kim, Y. Wolf, A. Mildner, D. Varol, M. Breker, D. Strauss-Ayali, S. Viukov, M. Guilliams, A. Misharin, et al. 2013. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 38:79-91. http://dx.doi.org/10.1016/j.immuni.2012.12.001
55. Zuliani, C., S. Kleber, S. Klussmann, T. Wenger, M. Kenzelmann, N. Schreglmann, A. Martinez, J.A. del Rio, E. Soriano, P. Vodrazka, et al. 2006. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ. 13:31-40. http://dx.doi.org/10.1038/sj.cdd.4401720